BioAge Labs Inc.
Last updated September 27, 2026
Organization details
- Legal name
- BioAge Labs Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Emeryville
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BIOA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001709941
- EIN
- 47-4721157
Board of directors
-
Eric Morgen · Director · Chief Operating OfficerSince 2024
- Since 2024
-
Jean Pierre Garnier · DirectorSince 2024
-
Kristen Fortney · Director · Chief Executive OfficerSince 2024
-
Michael H. Davidson · DirectorSince 2024
- Since 2024
-
Rekha Hemrajani · DirectorSince 2024
-
Vijay Satyanand Pande · DirectorSince 2024
Chief executives
Kristen Fortney
· Chief Executive Officer
Since September 2024
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
81.6%
-
89.0%
-
96.2%
Board connections
6 of this board's directors also sit on 17 other boards.
- via Rekha Hemrajani
- via James Healy
- via James Healy
- via Jean Pierre Garnier
- via Patrick G. Enright
- via Rekha Hemrajani
- via Rekha Hemrajani
- via James Healy
- via Vijay Satyanand Pande
- via Michael H. Davidson
- via James Healy
- via James Healy
- via Michael H. Davidson
- via Michael H. Davidson
- via Patrick G. Enright
- via Patrick G. Enright
- via Patrick G. Enright
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $7,793,412
- 13 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Barton Shane Officer (Principal Accounting Officer) | Option exercise | +4,290 | $10.85 | $46,547 |
| Jun 30, 2026 | Barton Shane Officer (Principal Accounting Officer) | Option exercise | +4,000 | $8.39 | $33,560 |
| Jun 30, 2026 | Barton Shane Officer (Principal Accounting Officer) | Option exercise | +4,065 | $4.30 | $17,480 |
| Jun 30, 2026 | Barton Shane Officer (Principal Accounting Officer) | Option exercise | +7,861 | $4.38 | $34,431 |
| Jun 30, 2026 | Barton Shane Officer (Principal Accounting Officer) | Open-market sale | −20,216 | $25.19 | $509,176 |
| Jun 29, 2026 | Barton Shane Officer (Principal Accounting Officer) | Option exercise | +9,301 | $10.85 | $100,916 |
| Jun 29, 2026 | Barton Shane Officer (Principal Accounting Officer) | Option exercise | +7,261 | $8.39 | $60,920 |
| Jun 29, 2026 | Barton Shane Officer (Principal Accounting Officer) | Option exercise | +8,958 | $4.30 | $38,519 |
| Jun 29, 2026 | Barton Shane Officer (Principal Accounting Officer) | Option exercise | +14,198 | $4.38 | $62,187 |
| Jun 29, 2026 | Barton Shane Officer (Principal Accounting Officer) | Open-market sale | −42,350 | $25.21 | $1,067,576 |
| Apr 23, 2026 | Dov A. Goldstein M.D. Officer (Chief Financial Officer) | Option exercise | +3,542 | $4.38 | $15,514 |
| Apr 1, 2026 | RUBIN PAUL D Officer (Chief Medical Officer) | Option exercise | +5,437 | $4.11 | $22,346 |
| Apr 1, 2026 | RUBIN PAUL D Officer (Chief Medical Officer) | Option exercise | +3,383 | $6.57 | $22,226 |
| Apr 1, 2026 | RUBIN PAUL D Officer (Chief Medical Officer) | Open-market sale | −8,820 | $17.81 | $157,084 |
| Mar 2, 2026 | RUBIN PAUL D Officer (Chief Medical Officer) | Option exercise | +5,433 | $4.11 | $22,330 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.